Navigation Links
ImmusanT Initiates Clinical Trials of Nexvax2 Therapeutic Vaccine for Celiac Disease
Date:9/4/2012

CAMBRIDGE, Mass., Sept. 4, 2012 /PRNewswire/ -- ImmusanT announced today that it has initiated clinical trials in New Zealand, Australia and the U.S. to evaluate Nexvax2®, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed to re-establish patients' tolerance to the toxic effects of gluten, a protein in wheat, barley and rye, and allow them to return to a normal diet. There are currently no approved medicines available for people with celiac disease, who must manage their condition by eliminating gluten-containing foods from their diet.

Advancing the earlier Nexvax2 clinical trial, the new program underway in Australia and New Zealand is a randomized, double-blind, placebo-controlled Phase 1b study evaluating multiple ascending doses of Nexvax2 for the induction of gluten tolerance in patients on a gluten-free diet. ImmusanT expects to enroll 84 subjects at approximately four study sites in the two countries in order to evaluate safety, tolerability and pharmacokinetics, and to select doses for investigation in subsequent studies.

The second study, a randomized, double-blind, placebo-controlled Phase 1 trial being conducted in the U.S. is to determine the safety, tolerability and pharmacokinetic profile of Nexvax2 in patients with celiac disease well controlled by a gluten-free diet. ImmusanT plans to enroll 30 adult subjects at approximately four trial sites.

"We are kicking-off a robust clinical program that we hope demonstrates Nexvax2 dramatically reduces the body's immune response to dietary gluten so patients can resume a normal diet and return to good health," said Patrick H. Griffin, M.D., Chief Medical Officer of ImmusanT. "Our clinical development program will allow us to further examine the role of antigen-specific T cells in celiac disease activation and in the re-establishment of tolerance to gluten."

"There has been tremendous enthusiasm about Nexvax2 from patients and the medica
'/>"/>

SOURCE ImmusanT Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ImmusanT Relocates Offices to State-of-the-Art Innovation Facility
2. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
3. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
4. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
5. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
6. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
7. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
8. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
9. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
10. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
11. Empire Asset Management Co. Initiates Coverage on Transcept Pharmaceuticals Inc., (NASDAQ: TSPT)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 16, 2014 This report analyzes the worldwide markets ... following Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin ... forecasts are provided for the period 2013 through 2020. Also, ...
(Date:9/16/2014)... 16, 2014  ROX Medical today presented positive ... prospective, randomized, controlled, blinded endpoint study of the ... CONTROL-HTN trial, NCT01642498, evaluated the safety and efficacy ... between a central artery and vein in the ... The primary outcomes are reduction of blood ambulatory ...
(Date:9/16/2014)... A study led by St. Jude ... dose threshold below which male childhood cancer survivors are ... in September 17 edition of the journal Lancet ... at highest risk for reduced sperm production as adults, ... pre-treatment fertility preservation methods such as sperm banking. ...
Breaking Medicine Technology:Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26ROX Medical presents positive data for CONTROL-HTN resistant hypertension trial 2Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4
... Cepheid (Nasdaq: CPHD ) today reported revenue for ... was $0.5 million, or $0.01 per share, which compares to ... million, or $(0.07) per share, in the first quarter of ... employee stock-based compensation expense, non-GAAP net income for the first ...
... 2011  Kinex Pharmaceuticals, LLC and Hanmi Pharmaceutical ... license agreement granting Hanmi Pharmaceuticals exclusive rights to ... in selected Asian Territories. KX01 (KX2-391) ... kinase/pretubulin dual mechanism inhibitor discovered and currently developed ...
Cached Medicine Technology:Cepheid Reports 2011 First Quarter Results 2Cepheid Reports 2011 First Quarter Results 3Cepheid Reports 2011 First Quarter Results 4Cepheid Reports 2011 First Quarter Results 5Cepheid Reports 2011 First Quarter Results 6Cepheid Reports 2011 First Quarter Results 7Cepheid Reports 2011 First Quarter Results 8Cepheid Reports 2011 First Quarter Results 9Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories 2Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories 3Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories 4
(Date:9/17/2014)... Washington, DC (PRWEB) September 17, 2014 ... family history. Along with regular screening and examination, a ... In this episode of Epicure with the Chef ... GWMFA Urologist Dr. Paul Rusilko to prepare a delicious ... in our western diets that influence risk of prostate ...
(Date:9/17/2014)... Neon Sport and Fitmark have an exclusive ... most anticipated event, Joe Weider's Olympia Fitness & Performance ... take home a Neon Sport branded Fitmark Power Duffel ... Fitmark will hold entries for the special prize at ... , “There’s nothing more exciting than seeing our collective ...
(Date:9/17/2014)... Acceleratio Ltd., an innovative software development ... of Server Monitoring Toolkit , a web ... It brings real-time server monitoring via a live ... enhanced features that significantly improve troubleshooting and detection ... agentless data collection, a user-friendly interface, and many ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Stand Up ... and music, returns to the Theater at Madison Square ... the Bob Woodruff Foundation (BWF) and New York Comedy ... returning service members, veterans and their families. , ... John Mulaney, John Oliver, Bruce Springsteen, Brian Williams and ...
(Date:9/17/2014)... 17, 2014 Kamut International is pleased ... key ingredient in Michael Angelo’s new “Made With Organic” ... fully organic lasagna ready made, frozen meal. Michael Angelo’s ... and these new products align well with Kamut International’s ... KAMUT® Brand wheat must be grown certified organic. , ...
Breaking Medicine News(10 mins):Health News:Boost Prostate Health with Epicure with the Chef MDs 2Health News:Electrifying Sports Nutrition Brand, Neon Sport, Pairs with Global Fitness Bag & Luggage Brand, Fitmark Bags, for an Exclusive Giveaway at Olympia Expo, This Weekend 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 3Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 2Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 3Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 4Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 5Health News:KAMUT® Brand Wheat Delivers a High Quality Ingredient and Authentic Italian Taste for Michael Angelo’s New Ready-Made Meals featuring Organic Ingredients 2
... An international team of researchers says abortion stigma is ... women who,ve had abortions. As a result, they,re launching ... stigma surrounding abortion. Their invited paper, "Abortion ... published in the current journal, Women,s Health Issues ...
... people every day, are a surprisingly common cause of ... hospital after sustaining stepladder injuries, many of which resulted ... how improved design and user behavior can decrease the ... HFES 55th Annual Meeting presentation, "The Role of Human ...
... (HealthDay News) -- Many members of low-income families are not ... In assessing the families, eating patterns and the nutritional ... 70 percent of the 100 families, who were newly enrolled ... amounts of several vital nutrients, including vitamins A and C, ...
... sorafenib responded to the flu vaccine, which suggests the ... as previously feared, according to a study in ... Association for Cancer Research. Keith Flaherty, M.D., ... and a senior editor of Clinical Cancer Research, said ...
... of scheduling chemotherapy treatments has been substantially reduced by a ... from the Sauder School of Business at the University of ... Called Chemo SmartBook, the innovative new scheduling system ... from the Health Employers Association of British Columbia in the ...
... many, a tax on soda is a no-brainer in advancing the ... in recent years that conclude that sugary drinks have a lot ... obese people tend to drink diet sodas, and therefore taxing soft ... weapon in combating obesity, according to a new Northwestern University study. ...
Cached Medicine News:Health News:International team explores the stigma surrounding abortion 2Health News:Improved stepladder design may decrease injuries 2Health News:Low-Income Families Often Miss Out on Proper Nutrition 2Health News:Patients treated with sunitinib and sorafenib respond to flu vaccine 2Health News:Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients 2Health News:Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients 3Health News:Can soda tax curb obesity? 2
ZyDoc offers a full medical transcription and documentation solution....
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: